Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LIVEKINDLY Collective is a private global plant-based food company that owns and operates a portfolio of alternative-protein brands, manufacturing sites, and B2B/private-label capabilities. Founded in 2020, the company was built to scale plant-based meat alternatives through a vertically integrated model spanning brand building, product development, manufacturing, and distribution. Its core consumer brands include Fry's, LIKE, Oumph!, No Meat, Alpha, and The Dutch Weed Burger, and its products are sold in more than 40 markets. LIVEKINDLY Collective also operates factories in Europe and South Africa and provides B2B and private-label production services. The company is not a biotech or pharmaceutical developer; it is a commercial food and alternative-protein platform focused on sustainable nutrition and plant-based consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LIVEKINDLY Collective.